Long-term outcomes of a bioactive matrix enriched with an autologous platelet concentrate for the treatment of complex anal fistulae - Takeaways - MDSpire

Long-term outcomes of a bioactive matrix enriched with an autologous platelet concentrate for the treatment of complex anal fistulae

  • By

  • I. Maya

  • E. Spada

  • M. Martí-Gallostra

  • A. Cirera de Tudela

  • G. Pellino

  • E. Espín-Basany

  • March 5, 2025

  • 0 min

Share

  • 1

    Complex anal fistulae (CAF) present significant surgical challenges, with high recurrence rates and complications, particularly in women and anterior fistulae.

  • 2

    Minimally invasive techniques for CAF aim to balance cure rates with sphincter function preservation, but long-term outcomes remain underreported.

  • 3

    The Obsidian RFT® matrix is a bioactive, autologous treatment option for CAF that promotes tissue regeneration and is compatible with various surgical approaches.

  • 4

    This pilot study evaluates long-term healing rates of CAF treated with RFT, assessing complications and effects on continence.

  • 5

    Inclusion criteria for the study included adults with CAF who had prior surgeries and completed at least six months of follow-up after RFT treatment.

Original Source(s)

Long-term outcomes of a bioactive matrix enriched with an autologous platelet concentrate for the treatment of complex anal fistulae

  • by I. Maya, E. Spada, M. Martí-Gallostra, A. Cirera de Tudela, G. Pellino, E. Espín-Basany

  • March 5, 2025

Related Content

Metabolic and Structural Alterations Linked to Mice's Vulnerability to Primary Echinostoma caproni Infections

Urologic malignancy risk with chronic tumor necrosis factor-alpha inhibitor (TNF-I) exposure: a multicenter, retrospective cohort study

Bioinformatics-driven insights: rapamycin-mediated CaMK2D inhibition alleviates intestinal ischemia-reperfusion injury